125 related articles for article (PubMed ID: 36481127)
21. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer.
Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W
World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116
[TBL] [Abstract][Full Text] [Related]
22. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
23. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases.
Zech CJ; Korpraphong P; Huppertz A; Denecke T; Kim MJ; Tanomkiat W; Jonas E; Ba-Ssalamah A;
Br J Surg; 2014 May; 101(6):613-21. PubMed ID: 24652690
[TBL] [Abstract][Full Text] [Related]
24. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
25. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis.
Vreugdenburg TD; Ma N; Duncan JK; Riitano D; Cameron AL; Maddern GJ
Int J Colorectal Dis; 2016 Nov; 31(11):1739-1749. PubMed ID: 27682648
[TBL] [Abstract][Full Text] [Related]
26. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
[TBL] [Abstract][Full Text] [Related]
28. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
Salem S; Houseni M; Zidan L; Kandil A
Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
[TBL] [Abstract][Full Text] [Related]
29. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
[TBL] [Abstract][Full Text] [Related]
30. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
[TBL] [Abstract][Full Text] [Related]
31. Cost-effective imaging for resectability of liver lesions in colorectal cancer: an economic decision model.
Saing S; Haywood P; Duncan JK; Ma N; Cameron AL; Goodall S
ANZ J Surg; 2018 Jun; 88(6):E507-E511. PubMed ID: 28982209
[TBL] [Abstract][Full Text] [Related]
32. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB
Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732
[TBL] [Abstract][Full Text] [Related]
33. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
[TBL] [Abstract][Full Text] [Related]
34. Impact of contrast-enhanced intraoperative ultrasound on operation strategy in case of colorectal liver metastasis.
Schulz A; Dormagen JB; Drolsum A; Bjørnbeth BA; Labori KJ; Kløw NE
Acta Radiol; 2012 Dec; 53(10):1081-7. PubMed ID: 23081954
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.
Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG
J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685
[TBL] [Abstract][Full Text] [Related]
36. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
[TBL] [Abstract][Full Text] [Related]
37. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
[TBL] [Abstract][Full Text] [Related]
39. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.
Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W
Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439
[TBL] [Abstract][Full Text] [Related]
40. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
